Have a personal or library account? Click to login
Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings Cover

Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings

The Journal of Critical Care Medicine
Volume 8 (2022): Issue 4 (October 2022)
By: Rashid Nadeem,  Islam Bon,  Doaa Algohary,  Mohd Kafeel Khan,  Nilesh Gundawar,  Mohammed Abdullah,  Ekta Sharma,  Moatz Galal Elzeiny,  Mayada Mahmoud,  Ashraf Elhoufi,  Yusra Omar Alshaikh Sayed Ahmed,  Gloria Gheno,  Maged Talaat Salama Khalil and  Tamseela Hussain  
Open Access
|Nov 2022

References

  1. Mallah, S.I., Ghorab, O.K., Al-Salmi, S., et al. COVID-19: breaking down a global health crisis. Annals of clinical microbiology and antimicrobials, 2021;20(1), pp.1-36.
    Search in Google ScholarBack to article
  2. Huang, C, Yeming W, Xingwang L, et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” The Lancet 395, no. 10223, (2020): 497-506.
    Search in Google ScholarBack to article
  3. Horby, P., Lim, W.S. and Landray, M.J. et al. Dexamethasone in hospitalized patients with Covid-19. The New England journal of medicine, 2021; 8(384), pp.693-704.
    Search in Google ScholarBack to article
  4. Dequin, PF., Heming, N., Meziani, F., et al. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. Jama, 2020; 324(13), pp.1298-1306.
    Search in Google ScholarBack to article
  5. Angus DC, Derde L, Al-Beidh F, et al. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. Jama. 2020;324(13):1317-29.
    Search in Google ScholarBack to article
  6. Jeronimo CM, Farias ME, Val FF, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019: a randomized, double-blind, phase IIb, placebo-controlled trial. Clinical Infectious Diseases. 2021;72(9): e373-81.
    Search in Google ScholarBack to article
  7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical care medicine. 1985;13(10):818-29.
    Search in Google ScholarBack to article
  8. Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. Journal of general internal medicine. 2013;28(11):1504-10.
    Search in Google ScholarBack to article
  9. Obata R, Maeda T, Rizk D, Kuno T. Increased secondary infection in COVID-19 patients treated with steroids in New York City. Jpn J Infect Dis. 2021 Jul 21;74(4):307-15.
    Search in Google ScholarBack to article
  10. Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia. 2020;34(6):1503-11.
    Search in Google ScholarBack to article
  11. Xu K, Chen Y, Yuan J. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020. [EPUB ahead of the print]
    Search in Google ScholarBack to article
  12. Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clinical Microbiology and Infection. 2021;27(1):83-8.
    Search in Google ScholarBack to article
  13. Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(1530-1539):10-16.
    Search in Google ScholarBack to article
  14. Bowyer SL, LaMothe MP, Hollister JR. Steroid myopathy: incidence and detection in a population with asthma. Journal of allergy and clinical immunology. 1985;76(2):234-42.
    Search in Google ScholarBack to article
  15. Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ open. 2014;4(5):e004587.
    Search in Google ScholarBack to article
  16. Goforth P, Gudas CJ. Effects of steroids on wound healing: a review of the literature. The Journal of foot surgery. 1980;19(1):22-8.
    Search in Google ScholarBack to article
  17. Ravindran NP, Halder A, Harshe D, Harshe S, Harshe G. A qualitative analysis of literature reporting and linking psychosis to COVID-19 infection. Asian journal of psychiatry. 2022:103099.
    Search in Google ScholarBack to article
  18. Nadeem R, Aijazi I, Elhoufi A, et al. Clinical Profile of Mortality and Treatment Profile of Survival in Patients with COVID-19 Pneumonia Admitted to Dubai Hospital. Dubai Medical Journal. 2021;4(2):170-6.
    Search in Google ScholarBack to article
  19. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clinical Infectious Diseases. 2000;31(5):1170-4.
    Search in Google ScholarBack to article
  20. Lino K, Guimarães GM, Alves LS, et al. Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality. Brazilian Journal of Infectious Diseases. 2021;25.
    Search in Google ScholarBack to article
  21. Ali A, Noman M, Guo Y, et al. Myoglobin and C-reactive protein are efficient and reliable early predictors of COVID-19 associated mortality. Scientific reports. 2021 Mar 16;11(1):1-3.
    Search in Google ScholarBack to article
  22. Ahmed Y, Cao A, Thal A, et al. Tracheotomy outcomes in 64 ventilated COVID‐19 patients at a high‐volume center in Bronx, NY. The Laryngoscope. 2021;131(6):E1797-804.
    Search in Google ScholarBack to article
  23. Bayrak V, Durukan NŞ, Aydemir FD, et al. Risk factors associated with mortality in ıntensive care COVID-19 patients: the importance of chest CT score and intubation timing as risk factors. Turkish journal of medical sciences. 2021;51(4):1665-74.
    Search in Google ScholarBack to article
  24. Lora-Tamayo J, Maestro G, Lalueza A, et al. Early Lopinavir/ ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. Journal of Infection. 2021;82(6):276-316.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/jccm-2022-0025 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 259 - 265
Submitted on: Sep 11, 2021
|
Accepted on: Sep 11, 2022
|
Published on: Nov 12, 2022
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
COVID-19,
infection,
steroids,
ARDS
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other,
Anaesthesiology,
Emergency medicine and intensive-care medicine

© 2022 Rashid Nadeem, Islam Bon, Doaa Algohary, Mohd Kafeel Khan, Nilesh Gundawar, Mohammed Abdullah, Ekta Sharma, Moatz Galal Elzeiny, Mayada Mahmoud, Ashraf Elhoufi, Yusra Omar Alshaikh Sayed Ahmed, Gloria Gheno, Maged Talaat Salama Khalil, Tamseela Hussain, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 8 (2022): Issue 4 (October 2022)Next article